| 30.0664 -1.163 (-3.72%) | 04-24 15:54 | |||||||||||||
|
|
| Short term |  |
|||
| Mid term |  |
|||
| Targets | 6-month : | 36.78 | 1-year : | 38.4 |
| Resists | First : | 31.49 | Second : | 32.88 |
| Pivot price | 31.81 |
|||
| Supports | First : | 29.24 | Second : | 24.33 |
| MAs | MA(5) : | 31.27 |
MA(20) : | 31.54 |
| MA(100) : | 32.3 |
MA(250) : | 0 | |
| MACD | MACD : | -0.3 |
Signal : | -0.2 |
| %K %D | K(14,3) : | 5.1 |
D(3) : | 27.6 |
| RSI | RSI(14): 38.9 |
|||
| 52-week | High : | 38.22 | Low : | 25.27 |
Price has closed below its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is BEARISH in short-term; and NEUTRAL in mid-long term.[ TBXU ] has closed below the lower bollinger band by 3.1%. Although price has broken the lower band and a downside breakout is possible; the most likely direction for [ TBXU ] is to continue within current trading range. Bollinger Bands are 28.8% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.
| If tomorrow: | Open lower | Open higher |
| High: | 30.57 - 30.82 | 30.82 - 30.99 |
| Low: | 29.55 - 29.82 | 29.82 - 30.01 |
| Close: | 29.71 - 30.13 | 30.13 - 30.42 |
The Direxion Daily Biotech Top 5 Bull 2X ETF seeks daily investment results, before fees and expenses, of 200% of the performance of the NYSE Biotechnology Top 5 Equal Weight Index. There is no guarantee the fund will achieve its stated investment objectives.
Mon, 02 Feb 2026
LABD: ETF To Benefit From Downturns In The Biotech Industry (NYSEARCA:LABD) - Seeking Alpha
Sun, 01 Feb 2026
CURE: Benefits And Caveats Of The Leveraged Healthcare ETF (NYSEARCA:CURE) - Seeking Alpha
Fri, 23 Jan 2026
LABU: The Risks And Rewards Of A Leveraged Biotechnology ETF (NYSEARCA:LABU) - Seeking Alpha
Mon, 08 Dec 2025
Top 5 Energy Titans: Cash Machines or Out of Gas? - Direxion
Fri, 28 Nov 2025
Can Biotech’s Top 5 Revive the Sector’s Pulse? - Direxion
Wed, 01 Oct 2025
TBXU Stock Fund Price and Chart — AMEX:TBXU - TradingView
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Neutral |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Neutral |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Neutral |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Neutral |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Neutral |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Neutral |
|
Exchange:
AMEX
|
|
|
Sector:
Healthcare
|
|
|
Industry:
Biotechnology
|
|
| Shares Out | 0 (M) |
| Shares Float | 0 (M) |
| Held by Insiders | 0 (%) |
| Held by Institutions | 0 (%) |
| Shares Short | 0 (K) |
| Shares Short P.Month | 0 (K) |
| EPS | 0 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | 0 |
| Profit Margin | 0 % |
| Operating Margin | 0 % |
| Return on Assets (ttm) | 0 % |
| Return on Equity (ttm) | 0 % |
| Qtrly Rev. Growth | 0 % |
| Gross Profit (p.s.) | 0 |
| Sales Per Share | 0 |
| EBITDA (p.s.) | 0 |
| Qtrly Earnings Growth | 0 % |
| Operating Cash Flow | 0 (M) |
| Levered Free Cash Flow | 0 (M) |
| PE Ratio | 0 |
| PEG Ratio | 0 |
| Price to Book value | 0 |
| Price to Sales | 0 |
| Price to Cash Flow | 0 |
| Dividend | 0 |
| Forward Dividend | 0 |
| Dividend Yield | 0% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |
|
|
|
|
|
|
|
|
|